Sinopharm Group Co. Ltd. (FRA:X2S)
Germany
· Delayed Price · Currency is EUR 2.237
+0.001 (0.04%)
At close: Dec 4, 2025
Sinopharm Group Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 3, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 7,085 | 8,266 | 7,391 | 7,430 | 5,968 | 6,206 | Upgrade
|
| Market Cap Growth | -7.69% | 11.84% | -0.53% | 24.49% | -3.83% | -35.75% | Upgrade
|
| Enterprise Value | 18,479 | 22,244 | 18,412 | 17,812 | 16,952 | 13,753 | Upgrade
|
| Last Close Price | 2.24 | 2.55 | 2.16 | 2.09 | 1.61 | 1.69 | Upgrade
|
| PE Ratio | 8.36 | 8.86 | 6.40 | 6.42 | 5.56 | 6.90 | Upgrade
|
| PS Ratio | 0.10 | 0.11 | 0.10 | 0.10 | 0.08 | 0.11 | Upgrade
|
| PB Ratio | 0.45 | 0.49 | 0.48 | 0.50 | 0.43 | 0.55 | Upgrade
|
| P/TBV Ratio | 0.82 | 0.89 | 0.90 | 0.95 | 0.84 | 1.08 | Upgrade
|
| P/FCF Ratio | 3.12 | 6.20 | 3.81 | 2.91 | 5.96 | 5.35 | Upgrade
|
| P/OCF Ratio | 2.93 | 5.41 | 3.37 | 2.61 | 4.63 | 4.44 | Upgrade
|
| EV/Sales Ratio | 0.27 | 0.29 | 0.24 | 0.24 | 0.24 | 0.24 | Upgrade
|
| EV/EBITDA Ratio | 6.60 | 8.42 | 5.91 | 5.30 | 5.35 | 5.26 | Upgrade
|
| EV/EBIT Ratio | 8.23 | 9.43 | 6.47 | 5.77 | 5.84 | 5.75 | Upgrade
|
| EV/FCF Ratio | 8.14 | 16.68 | 9.49 | 6.97 | 16.93 | 11.86 | Upgrade
|
| Debt / Equity Ratio | 0.63 | 0.60 | 0.61 | 0.63 | 0.69 | 0.76 | Upgrade
|
| Debt / EBITDA Ratio | 3.79 | 3.42 | 2.78 | 2.60 | 2.76 | 3.04 | Upgrade
|
| Debt / FCF Ratio | 4.39 | 7.58 | 4.85 | 3.69 | 9.45 | 7.40 | Upgrade
|
| Asset Turnover | - | 1.51 | 1.60 | 1.58 | 1.61 | 1.57 | Upgrade
|
| Inventory Turnover | - | 8.83 | 9.06 | 8.98 | 9.68 | 9.28 | Upgrade
|
| Quick Ratio | 1.07 | 1.06 | 1.06 | 0.99 | 1.01 | 0.99 | Upgrade
|
| Current Ratio | 1.35 | 1.39 | 1.40 | 1.36 | 1.33 | 1.31 | Upgrade
|
| Return on Equity (ROE) | - | 8.44% | 13.03% | 13.68% | 13.78% | 14.50% | Upgrade
|
| Return on Assets (ROA) | - | 2.87% | 3.73% | 4.06% | 4.06% | 4.11% | Upgrade
|
| Return on Capital (ROIC) | - | 5.61% | 7.46% | 8.18% | 8.03% | 8.22% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.20% | 12.50% | 15.70% | 17.50% | 18.10% | 17.80% | Upgrade
|
| Earnings Yield | 11.96% | 11.29% | 15.63% | 15.57% | 17.99% | 14.50% | Upgrade
|
| FCF Yield | 32.04% | 16.13% | 26.26% | 34.39% | 16.78% | 18.68% | Upgrade
|
| Dividend Yield | 3.64% | 3.53% | 5.14% | 5.33% | 6.45% | 5.12% | Upgrade
|
| Payout Ratio | 10.73% | 38.51% | 28.26% | 27.45% | 27.75% | 25.95% | Upgrade
|
| Buyback Yield / Dilution | 0.36% | - | -0.12% | 0.12% | -0.30% | -4.70% | Upgrade
|
| Total Shareholder Return | 4.00% | 3.53% | 5.03% | 5.46% | 6.15% | 0.42% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.